未登录.png)
分享.png)
收藏Successful management of recurrent multiple intracerebral TFE3-rearranged epithelioid hemangioendothelioma with repeated intervention and active surveillance: illustrative case成功管理复发性多发性颅内TFE3易位性上皮样血管肉瘤的案例：重复干预与主动监测
Matsui, Yasuzumi; Takada, Shigeki; Takeuchi, Yasuhide; Tokunaga, Shinya; Hattori, Etsuko Yamamoto; Ikeda, Hiroyuki; Sano, Noritaka; Tanji, Masahiro; Mineharu, Yohei; Arakawa, Yoshiki 分享 收藏 分享 收藏 分享 收藏 Efficacy of probiotics and trimebutine maleate for abemaciclib-induced diarrhea: A randomized, open-label phase II trial (MERMAID, WJOG11318B)Masuda, Hiroko; Tanabe, Yuko; Sakai, Hitomi; Matsumoto, Koji; Shimomura, Akihiko; Doi, Mihoko; Miyoshi, Yasuo; Takahashi, Masato; Sagara, Yasuaki; Tokunaga, Shinya; Iwasa, Tsutomu; Niikura, Naoki; Yoshimura, Kenichi; Takano, Toshimi; Tsurutani, Junji 分享 收藏 High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin as the first-line chemotherpy. Combined analysis of two phase 2 studyTakashima, Tsutomu; Kimura, Kosei; Kawajiri, Hidemi; Kashiwagi, Shinichiro; Tokunaga, Shinya; Nishimura, Shigehiko; Noda, Satoru; Oku, Hiroyo; Ikari, Ayana; Tominaga, Tomo; Maezawa, Saki; Sakane, Junna; Iwamoto, Mitsuhiko 分享 收藏 Phase II randomized study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea in patients with HR-positive and HER2-negative advanced breast cancer (MERMAID) WJOG11318BMasuda, H.; Tanabe, Y.; Matsumoto, K.; Shimomura, A.; Doi, M.; Miyoshi, Y.; Takahashi, M.; Sagara, Y.; Tokunaga, S.; Iwasa, T.; Niikura, N.; Yoshimura, K.; Takano, T.; Tsurutani, J. 分享 收藏 A phase II study of first-line chemotherapy initiating FOLFIRI plus cetuximab and switching to FOLFIRI plus bevacizumab according to early tumor shrinkage at 8 weeks in RAS wild-type metastatic colorectal cancer: HYBRID trialShoji, H.; Tsuda, T.; Shimokawa, M.; Akiyoshi, K.; Tokunaga, S.; Kunieda, K.; Kotaka, M.; Matsumoto, T.; Nagata, Y.; Mizukami, T.; Mizuki, F.; Danenberg, K.; Sunakawa, Y.; Boku, N.; Nakajima, T. 分享 收藏 分享 收藏 Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)帕尼单抗加伊立替康与西妥昔单抗加伊立替康在氟嘧啶，伊立替康和奥沙利铂难治性KRAS野生型转移性结直肠癌患者中的随机II期研究 (WJOG 6510G)Sakai, Daisuke; Taniguchi, Hiroya; Sugimoto, Naotoshi; Tamura, Takao; Nishina, Tomohiro; Hara, Hiroki; Esaki, Taito; Denda, Tadamichi; Sakamoto, Takeshi; Okuda, Hiroyuki; Satoh, Taroh; Tsushima, Takahiro; Makiyama, Akitaka; Tsuda, Takashi; Hosokawa, Ayumu; Kuramochi, Hidekazu; Tokunaga, Shinya; Moriwaki, Toshikazu; Yasui, Hisateru; Ishida, Hiroyasu; Tsuji, Akihito; Otsu, Satoshi; Shimokawa, Hozumi; Baba, Eishi; Sato, Mikio; Matsumoto, Shigemi; Ozaki, Yukinori; Shinozaki, Katsunori; Tamagawa, Hiroshi; Goto, Masahiro; Kadowaki, Shigenori; Fujii, Hirofumi; Koh, Yasuhiro; Yamazaki, Kentaro; Hironaka, Shuichi; Kishimoto, Junji; Boku, Narikazu; Hyodo, Ichinosuke; Muro, Kei 分享 收藏 Differences in disease status between patients with progression after first-line chemotherapy versus early relapse after adjuvant chemotherapy who undergo second-line chemotherapy for gastric cancer: Exploratory analysis of the randomized phase III TRICS trialNishikawa, Kazuhiro; Murotani, Kenta; Fujitani, Kazumasa; Inagaki, Hitoshi; Akamaru, Yusuke; Tokunaga, Shinya; Takagi, Masakazu; Tamura, Shigeyuki; Sugimoto, Naotoshi; Shigematsu, Tadashi; Yoshikawa, Takaki; Ishiguro, Tohru; Nakamura, Masato; Hasegawa, Hiroko; Morita, Satoshi; Miyashita, Yumi; Tsuburaya, Akira; Sakamoto, Junichi; Tsujinaka, Toshimasa 分享 收藏 Phase II study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea in patients with ER-positive and HER2-negative advanced breast cancer (MERMAID) WJOG11318BMasuda, Hiroko; Iwasa, Tsutomu; Mukohara, Toru; Tokunaga, Shinya; Matsumoto, Koji; Niikura, Naoki; Sagara, Yasuaki; Miyoshi, Yasuo; Shimomura, Akihiko; Takahashi, Masato; Nagashima, Takeshi; Doi, Mihoko; Futamura, Manabu; Yoshimura, Kenichi; Takano, Toshimi; Tsurutani, Junji 分享 收藏 Various immuno-related adverse events after IPI plus NIVO therapy; a case report of metastatic choroidal melanomaYoshii, Yumi; Okazaki, Shunsuke; Nakatani, Yuki; Tsuboguchi, Yuko; Akiyoshi, Kohei; Ueda, Shinya; Tokunaga, Shinya; Shimozono, Masataka; Goto, Hitoshi; Fukai, Kazuyoshi; Daga, Haruko 分享 收藏 分享 收藏 Chemotherapy-induced nausea and vomiting in patients with breast cancer: a prospective cohort study乳腺癌患者化疗引起的恶心和呕吐: 一项前瞻性队列研究Naito, Yoichi; Kai, Yuichiro; Ishikawa, Takashi; Fujita, Tomoyuki; Uehara, Kanou; Doihara, Hiroyoshi; Tokunaga, Shinya; Shimokawa, Mototsugu; Ito, Yoshinori; Saeki, Toshiaki 分享 收藏 Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)HER2-positive胃癌的五周S-1加顺铂治疗联合曲妥珠单抗治疗: II期试验和生物标志物研究 (WJOG7212G)Miura, Yuji; Sukawa, Yasutaka; Hironaka, Shuichi; Mori, Misuzu; Nishikawa, Kazuhiro; Tokunaga, Shinya; Okuda, Hiroyuki; Sakamoto, Takeshi; Taku, Keisei; Nishikawa, Kazuo; Moriwaki, Toshikazu; Negoro, Yuji; Kimura, Yutaka; Uchino, Keita; Shinozaki, Katsunori; Shinozaki, Hiroharu; Musha, Nobuyuki; Yoshiyama, Hirotsugu; Tsuda, Takashi; Miyata, Yoshinori; Sugimoto, Naotoshi; Shirakawa, Tsuyoshi; Ito, Miki; Yonesaka, Kimio; Yoshimura, Kenichi; Boku, Narikazu; Nosho, Katsuhiko; Takano, Toshimi; Hyodo, Ichinosuke 分享 收藏 Clinical significance of serum factors relating to ERBB signal pathways in a phase II trial of S-1 plus cisplatin combined with trastuzumab for HER2-positive advanced gastric or esophagogastric junction cancer: WJOG7212G (T-SPACE) TR studySukawa, Y.; Nosho, K.; Miura, Y.; Takano, T.; Ito, M.; Yonesaka, K.; Mori, M.; Tokunaga, S.; Kawada, J.; Okuda, H.; Sakamoto, T.; Hirashima, Y.; Uchino, K.; Miyata, Y.; Yoshimura, K.; Yamazaki, K.; Hironaka, S.; Boku, N.; Hyodo, I.; Muro, K. 分享 收藏 Randomised phase III trial of second-line irinotecan plus cisplatin versus irinotecan alone in patients with advanced gastric cancer refractory to S-1 monotherapy: TRICS trialNishikawa, Kazuhiro; Fujitani, Kazumasa; Inagaki, Hitoshi; Akamaru, Yusuke; Tokunaga, Shinya; Takagi, Masakazu; Tamura, Shigeyuki; Sugimoto, Naotoshi; Shigematsu, Tadashi; Yoshikawa, Takaki; Ishiguro, Tohru; Nakamura, Masato; Morita, Satoshi; Miyashita, Yumi; Tsuburaya, Akira; Sakamoto, Junichi; Tsujinaka, Toshimasa 分享 收藏 The influence of axillary reverse mapping related factors on lymphedema in breast cancer patientsIkeda, K.; Ogawa, Y.; Kajino, C.; Deguchi, S.; Kurihara, S.; Tashima, T.; Goto, W.; Nishiguchi, Y.; Tokunaga, S.; Fukushima, H.; Inoue, T. 分享 收藏 RANDOMIZED PHASE III TRIAL OF APREPITANT COMPARED WITH DEXAMETHASONE FOR EMESIS INDUCED BY CARBOPLATINDaga, H.; Kinbara, S.; Katsushima, U.; Okada, H.; Tsuya, A.; Taira, K.; Tokunaga, S.; Nakao, M.; Yoshida, T.; Takeda, K. 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
